Erythropoietin (EPO) and Altitude: Why Athletes Train in the Mountains

Introduction

“Altitude training” is nearly every endurance athlete’s dream. From Kenyan runners to Tour de France riders, virtually all of them conduct periodic training at high-altitude bases of 1,800–2,500 m. The core physiological mechanism is: hypoxia-inducible factor HIF-1α → erythropoietin EPO → increased red blood cell mass → enhanced oxygen-carrying capacity. This article, grounded in altitude-training research by Levine, Stray-Gundersen, and others, breaks down the true timeline of EPO’s effects.

HIF-1α: The Cell’s Oxygen Sensor

HIF-1α (Hypoxia-Inducible Factor-1α) was the subject of the 2019 Nobel Prize in Physiology or Medicine. Under normoxia, it is hydroxylated by PHD enzymes and degraded; under hypoxia, PHD activity declines, HIF-1α accumulates and enters the nucleus, activating more than 200 genes, including:

• The EPO gene in renal proximal tubular cells
• Vascular endothelial growth factor VEGF
• Glucose transporter GLUT1
• Nitric oxide synthase eNOS

The Timeline from EPO Elevation to Effect

Why Choose 1,800–2,500 m Altitude

Too low (<1,500 m): insufficient hypoxic stimulus, weak EPO response.
Too high (>3,000 m): training quality declines, muscle synthesis is inadequate, and the net effect may be negative.
Sweet spot 2,000–2,500 m: stimulates EPO while maintaining training intensity (the core of live-high train-low).

In Taiwan, suitable locations for extended stays at 2,000–2,500 m are limited: Cingjing (1,750 m) is too low, Songxue Lodge (3,150 m) is too high, and the more ideal options are the Hehuan Creek cabin area and the vicinity of Siyuan Pass (1,950 m).

Individual Differences: High Responders and Low Responders

Levine’s research shows that approximately 30% of athletes are “high responders,” with Hb increasing >1 g/dL after going to altitude; approximately 20% are “low responders,” showing almost no response. The difference stems from EPOR receptor gene polymorphisms and baseline iron stores.

Practical Recommendations

• Begin iron supplementation 4 weeks before going to altitude: serum ferritin should be >35 ng/mL; otherwise, elevated EPO has no raw material for hematopoiesis.
• Avoid inflammation: infection and inflammation (hepcidin↑) block iron absorption; reduce high-intensity training one week before going to altitude.
• Don’t climb too high: above 3,000 m, training quality declines and the net effect may worsen.
• Race timing after returning to sea level: the literature shows performance is best on days 1–3 or days 14–21 after returning to sea level, with a “transition period” in between on days 4–13.
• Wuling cycling team training camps: a 3-day camp is mainly for technical and psychological preparation; do not expect EPO red blood cell effects.

Conclusion

EPO is the true hero of altitude training, but it requires three elements to align: time (21–28 days), altitude (1,800–2,500 m), and materials (iron). Understanding the physiological timeline of HIF-1α and EPO is the only way to ensure that Taiwanese athletes’ investment in altitude training is not wasted.

Related Reading

• Altitude Adaptation for Running: How High-Altitude Training Stimulates Red Blood Cell Production and Enhances Endurance
• The Mechanisms of High-Altitude Hypoxic Training: The Science of Hypoxia-Inducible Factor HIF and Red Blood Cell Production
• The EPO Effect of Cycling Altitude Training: Scientific Principles and Applications in Taiwan
• The Physiology of Altitude Training: EPO, Hemoglobin, and the Oxygen Transport Chain